PEOPLE - Changes at Arthro Kinetics:
This article was originally published in Clinica
Arthro Kinetics (Esslingen, Stuttgart), a developer of biological implants for joint regeneration and surgical systems for minimally-invasive spinal surgery, has promoted Jason Loveridge to CEO. Previously a non-executive director, Dr Loveridge's 18 years in the biotech industry include periods at BioPharma Capital (specialist asset manager for life science companies), of which he was a co-founder; venture capitalist: Korda & Co (specialist early-stage investor); and senior member at JAFCO Nomura (a global life sciences investment committee).
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.